| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |